Physician profile
Mark C Domanski
NPI 1992993885
$6,168.78
in general payments reported to CMS, 2019-2025
20 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,778 · 2020: $683 · 2021: $668 · 2022: $1,252 · 2023: $505 · 2024: $757 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,787.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $1,410.40 | 2019-2022 | |
| Smith+Nephew, INC. | $1,302.65 | 2019-2023 | Grafix |
| Integra Lifesciences Corporation | $733.51 | 2019-2025 | Integra, Tenoglide, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $377.22 | 2020-2024 | Trumatch, Matrixmandible |
| Galderma Laboratories, L.P. | $317.94 | 2020-2023 | |
| Baxter Healthcare | $267.30 | 2020-2024 | |
| Access Pro Medical, LLC | $190.91 | 2025 | Matriderm |
| Mentor Worldwide LLC | $190.28 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Cg Infiltration Tubing |
| Innovation Technologies INC | $183.74 | 2023 | Irrisept |
| Axogen | $178.47 | 2022 | |
| Motiva USA, LLC | $160.50 | 2025 | |
| Zimmer Biomet Holdings, INC. | $134.80 | 2020 | |
| Coopersurgical, INC. | $134.44 | 2019 | |
| Zimvie INC. | $119.90 | 2022 | |
| Avita Medical Americas, LLC | $118.10 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $107.30 | 2024 | Conextions Tr Tendon Repair System-Implant Mechanism, Vsp System, Vsp Cranial, Na |
| Bard Peripheral Vascular, INC. | $105.18 | 2021 | |
| Biocircuit Technologies INC | $74.13 | 2024 | |
| Sanara Medtech INC. | $44.01 | 2024 | Celleraterx |
| Checkpoint Surgical, INC | $18.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Domanski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.